|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-34 |
|
Veke 21-33 |
|
Veke 21-32 |
|
Veke 21-31 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Bordetella parapertussis |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Mycoplasma pneumoniae |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Chlamydia pneumoniae |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Influensavirus A |
444 |
<5 |
|
|
439 |
<5 |
|
|
437 |
<5 |
|
|
352 |
<5 |
|
|
|
Influensavirus B |
444 |
<5 |
|
|
439 |
<5 |
|
|
437 |
<5 |
|
|
352 |
<5 |
|
|
|
Parainfluensavirus 1 |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Parainfluensavirus 2 |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Parainfluensavirus 3 |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
223 |
<5 |
|
|
224 |
<5 |
|
|
223 |
<5 |
|
|
174 |
<5 |
|
|
|
Humant metapneumovirus |
131 |
<5 |
|
|
120 |
<5 |
|
|
123 |
<5 |
|
|
106 |
<5 |
|
|
|
Rhinovirus |
131 |
15 |
11 % |
|
120 |
5 |
4 % |
|
123 |
6 |
5 % |
|
106 |
5 |
5 % |
|
|
SARS-CoV-2 |
582 |
7 |
1 % |
|
523 |
8 |
2 % |
|
526 |
10 |
2 % |
|
414 |
9 |
2 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-34 |
|
Veke 21-33 |
|
Veke 21-32 |
|
Veke 21-31 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
256 |
<5 |
|
|
190 |
<5 |
|
|
196 |
<5 |
|
|
181 |
<5 |
|
|
|
Bordetella parapertussis |
256 |
<5 |
|
|
190 |
<5 |
|
|
196 |
<5 |
|
|
181 |
<5 |
|
|
|
Mycoplasma pneumoniae |
256 |
<5 |
|
|
190 |
<5 |
|
|
196 |
<5 |
|
|
181 |
<5 |
|
|
|
Chlamydia pneumoniae |
256 |
<5 |
|
|
190 |
<5 |
|
|
196 |
<5 |
|
|
181 |
<5 |
|
|
|
Influensavirus A |
272 |
<5 |
|
|
204 |
<5 |
|
|
217 |
<5 |
|
|
206 |
<5 |
|
|
|
Influensavirus B |
272 |
<5 |
|
|
204 |
<5 |
|
|
217 |
<5 |
|
|
206 |
<5 |
|
|
|
Parainfluensavirus 1 |
256 |
<5 |
|
|
190 |
<5 |
|
|
196 |
<5 |
|
|
181 |
<5 |
|
|
|
Parainfluensavirus 2 |
256 |
<5 |
|
|
190 |
<5 |
|
|
196 |
<5 |
|
|
181 |
<5 |
|
|
|
Parainfluensavirus 3 |
256 |
27 |
11 % |
|
190 |
13 |
7 % |
|
196 |
5 |
3 % |
|
181 |
5 |
3 % |
|
|
Respiratorisk syncytialt virus |
270 |
<5 |
|
|
198 |
<5 |
|
|
211 |
<5 |
|
|
195 |
<5 |
|
|
|
Humant metapneumovirus |
256 |
<5 |
|
|
190 |
<5 |
|
|
196 |
<5 |
|
|
181 |
<5 |
|
|
|
Rhinovirus |
256 |
60 |
23 % |
|
190 |
32 |
17 % |
|
196 |
32 |
16 % |
|
181 |
27 |
15 % |
|
|
SARS-CoV-2 |
25782 |
926 |
4 % |
|
19527 |
637 |
3 % |
|
18388 |
647 |
4 % |
|
16389 |
627 |
4 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
01.09.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|